Literature DB >> 19473426

Mosaics and haemophilia.

C K Kasper1, C H Buzin.   

Abstract

Some mosaic conditions may affect the haemophilia phenotype. Well-known instances include chromosomal mosaicism because of aneuploidy and pseudo-mosaicism because of varying patterns of X-chromosome inactivation. Chromosomal mosaicism in a chimera is a potential source of phenotypic variation. Gene mosaicism is commonplace. Its pattern and effect depend on the stage of development at which a mutation occurs. Proven or possible genetic mosaicism is an important consideration when predicting the likelihood of transmission of haemophilia to a future generation. A mosaic is an individual who has two or more cell lines, genetically different with regard to chromosomes or genes. As techniques improve and studies accumulate, mosaics are being found to be more common than hitherto believed. Some mosaic conditions may affect the phenotype of haemophilia in males and of the carrier state in females. Cells may be mosaic with regard to chromosomes, as in some instances of aneuploidy, and in chimeras, and in females owing to the pattern of X-chromosome inactivation. Cells may be mosaic with regard to new gene mutations. The pattern of mosaicism depends upon the stage in embryogenesis or in germ-cell formation in which the mutation arose.

Entities:  

Mesh:

Year:  2009        PMID: 19473426     DOI: 10.1111/j.1365-2516.2009.02003.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  7 in total

Review 1.  Diagnosis and care of patients with mild haemophilia: practical recommendations for clinical management.

Authors:  Gary Benson; Günter Auerswald; Gerry Dolan; Anne Duffy; Cedric Hermans; Rolf Ljung; Massimo Morfini; Silva Zupančić Šalek
Journal:  Blood Transfus       Date:  2017-11-14       Impact factor: 3.443

2.  Detection of mosaics in hemophilia A by deep Ion Torrent sequencing and droplet digital PCR.

Authors:  Eric Manderstedt; Rosanna Nilsson; Rolf Ljung; Christina Lind-Halldén; Jan Astermark; Christer Halldén
Journal:  Res Pract Thromb Haemost       Date:  2020-09-07

3.  Future research and therapeutic applications of human stem cells: general, regulatory, and bioethical aspects.

Authors:  Antonio Liras
Journal:  J Transl Med       Date:  2010-12-10       Impact factor: 5.531

Review 4.  Hemophilia B: molecular pathogenesis and mutation analysis.

Authors:  A C Goodeve
Journal:  J Thromb Haemost       Date:  2015-05-18       Impact factor: 5.824

Review 5.  Developments in the treatment of hemophilia B: focus on emerging gene therapy.

Authors:  Maria I Cancio; Ulrike M Reiss; Amit C Nathwani; Andrew M Davidoff; John T Gray
Journal:  Appl Clin Genet       Date:  2013-10-18

Review 6.  Skewed Inactivation of X Chromosome: A Cause of Hemophilia Manifestation in Carrier Females.

Authors:  Hafiz Muhammad Hassan Shoukat; Ghulam Ghous; Zahid Ijaz Tarar; Muhammad Mohsin Shoukat; Namra Ajmal
Journal:  Cureus       Date:  2020-10-28

7.  Molecular analysis of 76 Chinese hemophilia B pedigrees and the identification of 10 novel mutations.

Authors:  Limin Huang; Liyan Li; Sheng Lin; Juanjuan Chen; Kun Li; Dongmei Fan; Wangjie Jin; Yihong Li; Xu Yang; Yufeng Xiong; Fenxia Li; Xuexi Yang; Ming Li; Qiang Li
Journal:  Mol Genet Genomic Med       Date:  2020-09-01       Impact factor: 2.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.